Show Notes
Hällqvist J et al., Nature Communications - Targeted multi-region lipidomics with proteomic and mitochondrial data reveals region- and stage-specific lipid alterations in Parkinson’s disease that converge on mitochondrial dysfunction. Key terms: lipids, parkinsons disease, putamen, ceramide, plasmalogens.
Study Highlights:
The study quantified 146 lipid species across eight anatomically distinct post-mortem brain regions in controls and mid- and late-stage Parkinson’s disease using targeted LC-MS/MS and integrated proteomics and mitochondrial assays. Control brains showed distinct regional lipid signatures and age-associated increases in hexosylceramides, while PD brains exhibited cortical elevations of gangliosides, HexCer and Hex2Cer and subcortical reductions of glycosphingolipids alongside increased sphingolipids and decreased phospholipids. The putamen displayed the most pronounced mid-stage changes with depletion of very long-chain ceramides and plasmalogen PE that normalized in late-stage disease, and lyso-phosphatidylcholine rose progressively with disease stage. Correlative multi-omic analysis linked sphingomyelin species to PD-related proteins and associated putaminal lipids including plasmalogens, long-chain ceramides, lyso-PC and HexCer with altered mitochondrial complex I activity.
Conclusion:
Region- and stage-specific lipid remodeling in Parkinson’s disease converges with mitochondrial dysfunction and identifies lipid pathways that may contribute to disease progression and therapeutic targeting
Music:
Enjoy the music based on this article at the end of the episode.
First author:
Hällqvist J
Journal:
Nature Communications
DOI:
10.1038/s41467-025-65489-2
Reference:
Hällqvist J, Toomey CE, Pinto R, Baldwin T, Doykov I, Wernick A, Al Shahrani M, Evans JR, Lachica J, Pope S, Heales S, Eaton S, Mills K, Gandhi S & Heywood WE. Multi-omic analysis reveals lipid dysregulation associated with mitochondrial dysfunction in Parkinson’s disease brain. Nature Communications. 2025;16:10490. https://doi.org/10.1038/s41467-025-65489-2
License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/
Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
Official website https://basebybase.com
On PaperCast Base by Base you’ll discover the latest in genomics, functional genomics, structural genomics, and proteomics.
Episode link: https://basebybase.com/episodes/lipid-dysregulation-parkinsons-brain
QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-12-06.
QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Substantive auditing of the transcript's scientific claims about regional lipid remodeling in PD, ceramide chain-length shifts, putamen-specific changes, mitochondrial correlations, and multi-omic integration, with attention to disease progression and potential protective responses.
- transcript topics: Regional lipid remodeling across eight brain regions; Ceramide chain-length alterations (short vs very long); Putamen mid-stage changes and plasmalogen PE; Glycosphingolipid patterns cortical vs subcortical; Lyso-phospholipids and plasmalogens across PD stages; Lipid-proteomics and mitochondrial complex I correlations
QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 8
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0
Metadata Audited:
- article_doi
- article_title
- article_journal
- license
Factual Items Audited:
- 8 anatomically distinct brain regions analyzed
- 146 lipid species quantified
- Braak staging used: mid-stage Braak 3-4 and late-stage Braak 5-6
- Putamen mid-stage shows depletion of very long-chain ceramides and plasmalogen PE
- Short-chain ceramides (C16, C18) elevated broadly in PD
- Cortical regions show increased glycosphingolipids (GM1, GM2, GM3) while subcortical regions show decreases
QC result: Pass.
